US Edition
Published • loading... • Updated
Prime Capital Investment Advisors LLC Reduces Position in Regeneron Pharmaceuticals, Inc. $REGN
Summary by themarketsdaily.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Prime Capital Investment Advisors LLC Reduces Position in Regeneron Pharmaceuticals, Inc. $REGN
Prime Capital Investment Advisors LLC trimmed its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 41.6% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 639 shares of the biopharmaceutical company’s stock after selling 456 shares during the period. Prime Capital Investment Advisors LLC’s holdings in Regeneron Pharmaceuticals were worth $336,000 at […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
